AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Zacks News
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is AMN Healthcare (AMN) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has AMN Healthcare Services (AMN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMN) Outperforming Other Medical Stocks This Year?
Will AMN Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services.
Teladoc (TDOC) Up 49% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) benefits from its fast growing healthcare business and international expansion.
Company News for Feb 18, 2020
by Zacks Equity Research
Companies In The News Are: AYX, AMN, ANET, RBS
Will AMN Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services.
AMN Healthcare (AMN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) Q4 results gain from core Nurse and Allied Solutions units.
Here's Why You Should Retain Integer Holdings Stock for Now
by Zacks Equity Research
Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales. However, intense competition remains a woe.
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
AMN Healthcare (AMN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Nurse and Allied Solutions segment drives AMN Healthcare's (AMN) third-quarter results.
Earnings Preview: AMN Healthcare Services (AMN) Q3 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why AMN Healthcare (AMN) Could Beat Earnings Estimates Again
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is AMN Healthcare (AMN) Up 5.6% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is AMN Healthcare Services (AMN) a Good Value Investor Pick?
by Zacks Equity Research
Let's see if AMN Healthcare Services (AMN) stock is a good choice for value-oriented investors right now from multiple angles.
Teladoc Up 33% Year to Date: Will the Momentum Continue?
by Zacks Equity Research
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.
AMN Healthcare (AMN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) issues upbeat revenue guidance for the third quarter of 2019.
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 10.00% and 1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
AMN or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
Earnings Preview: AMN Healthcare Services (AMN) Q2 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Near-Term Outlook for Medical Services Industry Looks Bright
by Urmimala Biswas
The third-party medical services industry is expanding rapidly.
AMN or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
HealthEquity (HQY) in Focus: Stock Moves 6.7% Higher
by Zacks Equity Research
HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.